Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NGM BIOPHARMACEUTICALS INC | Chief Financial Officer | Common Stock | 0 | $0 | $1.34 | Apr 5, 2024 | Direct |
NGM BIOPHARMACEUTICALS INC | Chief Financial Officer | Stock Option (Right to Buy) | 0 | Apr 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NGM | NGM BIOPHARMACEUTICALS INC | Mar 26, 2024 | 2 | $0 | 4 | Apr 8, 2024 | Chief Financial Officer |
NGM | NGM BIOPHARMACEUTICALS INC | Dec 1, 2023 | 1 | $0 | 4 | Dec 4, 2023 | Chief Financial Officer |
NGM | NGM BIOPHARMACEUTICALS INC | Nov 3, 2023 | 0 | $0 | 3 | Nov 8, 2023 | Chief Financial Officer |